Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A. B. Friedman
Editorial: An Argument for Low-Dose Thiopurine Allopurinol Combination Use as First-Line Therapy in Inflammatory Bowel Disease-Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Randomised Clinical Trial: Efficacy, Safety and Dosage of Adjunctive Allopurinol in Azathioprine/Mercaptopurine Nonresponders (AAA Study)
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Related publications
Editorial: An Argument for Low-Dose Thiopurine Allopurinol Combination Use as First-Line Therapy in Inflammatory Bowel Disease
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: Paradoxical Skin Lesions During Anti-TNF Treatment-An Additional Argument to Consider New Biologics as First-Line Therapy in Inflammatory Bowel Disease. Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: Treating Strictures in Inflammatory Bowel Disease-Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: Paradoxical Skin Lesions During Anti-TNF Treatment-An Additional Argument to Consider New Biologics as First Line Therapy in Inflammatory Bowel Disease
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: Thiopurine-Induced Myelosuppression and Infections in Inflammatory Bowel Disease Patients With a Normal TPMT Genotype-The Perils of Ageing. Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Editorial: Probiotics in Inflammatory Bowel Disease-Wrong Organisms, Wrong Disease, or Flawed Concepts? Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Infliximab Therapy for Patients With Inflammatory Bowel Disease - Some Unanswered Questions. Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Vedolizumab for Autoimmune Liver Disease Associated Inflammatory Bowel Disease-Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Letter: Screening for Adrenal Suppression in Paediatric Inflammatory Bowel Disease - Authors’ Reply
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
